Displaying drugs 226 - 250 of 7336 in total
Torasemide
Torasemide is a high-ceiling loop diuretic. Structurally, it is a pyridine-sulfonylurea used as an antihypertensive agent. Torasemide was first approved for clinical use by the FDA in 1993.
Approved
Matched Products: … TORASEMID 1A PHARMA 5 MG ... TORVENTA 5 MG TABLET, 20 ADET ... TORVENTA 5 MG TABLET, 30 ADET …
Altretamine
An alkylating agent proposed as an antineoplastic. It also acts as a chemosterilant for male houseflies and other insects.
Approved
Methimazole
Methimazole is a thionamide antithyroid agent that inhibits the synthesis of thyroid hormones.[A184559,A184733,A184694] It was first introduced as an antithyroid agent in 1949 and is now commonly used in the management of hyperthyroidism, particularly in those for whom more aggressive options such as surgery or radioactive iodine therapy are inappropriate.[L8336,L8339]...
Approved
Matched Products: … VELTHROM 5 ... THYROZOL 5 ... THYROZOL TABLET 5 mg …
Natamycin
Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. [PubChem]
Approved
Matched Iupac: … (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-{[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan …
Matched Products: … NATACYN 5% STERILE OPHTHALMIC SUSPENSION ... NATACYN ® 5% SUSPENSION OFTALMICA ESTERIL ... NATACYN (NATAMYCIN 5%) OPHTHALMIC SUSPENSION …
Matched Products: … NATACYN 5% STERILE OPHTHALMIC SUSPENSION ... NATACYN ® 5% SUSPENSION OFTALMICA ESTERIL ... NATACYN (NATAMYCIN 5%) OPHTHALMIC SUSPENSION …
Terbutaline
Terbutaline was first synthesized in 1966 and described in the literature in the late 1960s and early 1970s. It is a selective beta-2 adrenergic agonist used as a bronchodilator in asthmatic patients.[A230333,L32093,L32098]
Terbutaline was granted FDA approval on 25 March 1974.
Approved
Matched Iupac: … 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol …
Matched Salts cas: … 23031-32-5 …
Matched Mixtures name: … BİCANA 1.5 MG/5 ML+66.5 MG/5 ML ŞURUP, 100 ML ... BRELAX 1,5 MG+66,5 MG/5 ML ŞURUP, 100 ML ... BECONYL 1,5 MG + 66,5 MG / 5 ML ŞURUP, 100 ML …
Matched Products: … Bricanyl Tab 5 mg ... BUTYLIN SYRUP 1.5 mg/5 ml ... ASMALIN SYRUP 1.5 mg/5 ml …
Matched Salts cas: … 23031-32-5 …
Matched Mixtures name: … BİCANA 1.5 MG/5 ML+66.5 MG/5 ML ŞURUP, 100 ML ... BRELAX 1,5 MG+66,5 MG/5 ML ŞURUP, 100 ML ... BECONYL 1,5 MG + 66,5 MG / 5 ML ŞURUP, 100 ML …
Matched Products: … Bricanyl Tab 5 mg ... BUTYLIN SYRUP 1.5 mg/5 ml ... ASMALIN SYRUP 1.5 mg/5 ml …
Treosulfan
Treosulfan is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. Treosulfan has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood.
Approved
Investigational
Matched Products: … ALLOPRE 5 G İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 5 ADET ... ALLOPRE 5 G İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN TOZ, 1 ADET …
Flurbiprofen
Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. Oral formulations of flurbiprofen may be used for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. Flurbiprofen may also be used topically prior to ocular surgery to prevent or reduce intraoperative miosis....
Approved
Investigational
Matched Mixtures name: … MAJEZIK DUO %5 + %0.25 TOPIKAL JEL, 50 G ... MERDEX DUO %5 + %0.25 TOPIKAL JEL, 30 G ... MERDEX DUO %5 + %0.25 TOPIKAL JEL, 50 G …
Matched Products: … MAJEZIK %5 TOPIKAL JEL, 30 G ... MAJEZIK %5 TOPIKAL JEL, 50 G ... MAJEZIK % 5 TOPIKAL SPREY, ÇÖZELTİ, 50 ML …
Matched Products: … MAJEZIK %5 TOPIKAL JEL, 30 G ... MAJEZIK %5 TOPIKAL JEL, 50 G ... MAJEZIK % 5 TOPIKAL SPREY, ÇÖZELTİ, 50 ML …
Lorpiprazole
Lorpiprazole is a serotonin antagonist and reuptake inhibitor used for the treatment of major depressive disorder. It is a piperazinyl-triazole derivative.
Approved
Matched Iupac: … (1S,8R)-5-(2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}ethyl)-3,4,6-triazatricyclo[6.3.0.0²,⁶]undeca …
Matched Categories: … Serotonin 5-HT2 Receptor Antagonists ... Serotonin 5-HT2A Receptor Antagonists ... Serotonin 5-HT2C Receptor Antagonists …
Matched Categories: … Serotonin 5-HT2 Receptor Antagonists ... Serotonin 5-HT2A Receptor Antagonists ... Serotonin 5-HT2C Receptor Antagonists …
Amikacin
Amikacin is a semi-synthetic aminoglycoside antibiotic that is derived from kanamycin A.[FDA label] Amikacin is synthesized by acylation with the l-(-)-γ-amino-α-hydroxybutyryl side chain at the C-1 amino group of the deoxystreptamine moiety of kanamycin A. Amikacin's unique property is that it exerts activity against more resistant gram-negative bacilli such as...
Approved
Investigational
Vet approved
Matched Synonyms: … -D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA. ... -D-GLUCOPYRANOSYL-(1->4)-O-(6-AMINO-6-DEOXY-.ALPHA. ... -D-GLUCOPYRANOSYL-(1->6))-N(SUP 3)-(4-AMINO-L-2-HYDROXYBUTYRYL)-2-DEOXY-L-STREPTAMINE …
Matched Iupac: … (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl) ... oxan-2-yl]oxy}-4-{[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxycyclohexyl …
Matched Salts cas: … 39831-55-5 …
Matched Products: … LIKACIN GEL 5% ... Braun 5 mg/ml Infusionslösung ... AMIKAL 100 MG İNJEKTABL AMPUL, 5 ADET …
Matched Iupac: … (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl) ... oxan-2-yl]oxy}-4-{[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxycyclohexyl …
Matched Salts cas: … 39831-55-5 …
Matched Products: … LIKACIN GEL 5% ... Braun 5 mg/ml Infusionslösung ... AMIKAL 100 MG İNJEKTABL AMPUL, 5 ADET …
Pentoxifylline
Pentoxifylline (PTX) is a synthetic dimethylxanthine derivative that modulates the rheological properties of blood and also has both anti-oxidant and anti-inflammatory properties.[A226415, L30300] Although originally developed to treat intermittent claudication, a form of exertion-induced leg pain common in patients with peripheral arterial disease, PTX has been investigated for its possible...
Approved
Investigational
Matched Iupac: … 3,7-dimethyl-1-(5-oxohexyl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione …
Matched Mixtures name: … Betamethasone Dipropionate 0.05% / Minoxidil 5% / Niacinamide 2% / Pentoxifylline 0.5% …
Matched Categories: … Phosphodiesterase 5 Inhibitors …
Matched Products: … ONPENT 100 MG/5 ML İ.V. İNFÜZYONLUK ÇÖZELTİ , 5 ADET ... HEMOPENE 100 MG 5 ML 10 AMPUL ... VASOPLAN 100 MG/5 ML IM/IV AMPUL …
Matched Mixtures name: … Betamethasone Dipropionate 0.05% / Minoxidil 5% / Niacinamide 2% / Pentoxifylline 0.5% …
Matched Categories: … Phosphodiesterase 5 Inhibitors …
Matched Products: … ONPENT 100 MG/5 ML İ.V. İNFÜZYONLUK ÇÖZELTİ , 5 ADET ... HEMOPENE 100 MG 5 ML 10 AMPUL ... VASOPLAN 100 MG/5 ML IM/IV AMPUL …
Hydrocortisone
Hydrocortisone, or cortisol, is a glucocorticoid secreted by the adrenal cortex. Hydrocortisone is used to treat immune, inflammatory, and neoplastic conditions.[L10529,L10532,L10535,L10538,L7772,L7321] It was discovered in the 1930s by Edward Kendall and named Compound F, or 17-hydroxycorticosterone. Hydrocortisone was granted FDA approval on 5 August 1952.
Approved
Vet approved
Matched Description: … [A188420]
Hydrocortisone was granted FDA approval on 5 August 1952.[L10574] …
Matched Mixtures name: … HERPAZON % 5 + % 1 KREM, 5 GRAM ... HYDROCORTISONE 1% ET UREA 5% CREAM ... Hydrocortisone 0.5% / Hydroquinone 6% …
Matched Products: … LIMICORT® - 5 ... VESACORT ® 5 MG TABLETAS ... KORTAFGOR® 5 MG TABLETAS …
Matched Mixtures name: … HERPAZON % 5 + % 1 KREM, 5 GRAM ... HYDROCORTISONE 1% ET UREA 5% CREAM ... Hydrocortisone 0.5% / Hydroquinone 6% …
Matched Products: … LIMICORT® - 5 ... VESACORT ® 5 MG TABLETAS ... KORTAFGOR® 5 MG TABLETAS …
Ethambutol
Ethambutol is a bacteriostatic agent indicated alongside medications such as isoniazid, rifampin, and pyrazinamide in the treatment of pulmonary tuberculosis. Ethambutol was first described in the literature in 1961. It was developed out of a need for therapies active against isoniazid resistant strains of Mycobacterium tuberculosis. Ethambutol was granted FDA...
Approved
Matched Description: … [A229048]
Ethambutol was granted FDA approval on 6 November 1967.[L31663] …
Matched Mixtures name: … RIFAMPICIN 150 MG/ISONIAZID 75 MG/PYRAZINAMIDE 400 MG/ETHAMBUTOL 275 MG ... RIFAMPICINA 150 MG+ ISONIAZIDA 75 MG + PIRAZINAMIDA 400 MG+ ETAMBUTOL CLORHIDRATO 275 MG TABLETAS RECUBIERTAS …
Matched Mixtures name: … RIFAMPICIN 150 MG/ISONIAZID 75 MG/PYRAZINAMIDE 400 MG/ETHAMBUTOL 275 MG ... RIFAMPICINA 150 MG+ ISONIAZIDA 75 MG + PIRAZINAMIDA 400 MG+ ETAMBUTOL CLORHIDRATO 275 MG TABLETAS RECUBIERTAS …
Ruxolitinib
Ruxolitinib, formerly known as INCB018424 or INC424, is an anticancer drug and a Janus kinase (JAK) inhibitor. It is a potent and selective inhibitor of JAK1 and JAK2, which are tyrosine kinases involved in cytokine signalling and hematopoiesis. Myeloproliferative neoplasms, such as myelofibrosis and polycythemia vera, are often characterized by...
Approved
Matched Salts cas: … 1092939-16-6 …
Matched Products: … JAKAVI 5 MG (TABLETS) ... JAKAVI 5 MG TABLET, 168 TABLET ... JAKAVI 5 MG TABLET, 14 ADET …
Matched Products: … JAKAVI 5 MG (TABLETS) ... JAKAVI 5 MG TABLET, 168 TABLET ... JAKAVI 5 MG TABLET, 14 ADET …
Treprostinil
Treprostinil is a stable tricyclic analogue of prostacyclin that promotes the vasodilation of pulmonary and systemic arterial vascular beds and the inhibition of platelet aggregation.[L41855,L41860,L41865] It reduces symptoms in patients with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease.[L41855,L41860] The first agent approved for the treatment...
Approved
Investigational
Matched Iupac: … -{[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-1H,2H,3H,3aH,4H,9H,9aH-cyclopenta[b]naphthalen-5- …
Matched Description: … However, the use of epoprostenol is limited due to its short half-life (3-5 min) and instability at room …
Matched Products: … REMODULIN 5 mg/ml Infusionslösung ... Treposa 5 mg/ml Infusionslösung ... Trisuva 5 mg/ml Infusionslösung …
Matched Description: … However, the use of epoprostenol is limited due to its short half-life (3-5 min) and instability at room …
Matched Products: … REMODULIN 5 mg/ml Infusionslösung ... Treposa 5 mg/ml Infusionslösung ... Trisuva 5 mg/ml Infusionslösung …
Cholecalciferol
Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are...
Approved
Nutraceutical
Matched Iupac: … (1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-octahydro-1H-inden-4-ylidene]ethylidene …
Matched Mixtures name: … BONEPLUS D3 75 MG/2800 IU EFERVESAN TABLET, 6 ADET ... RISEPLUS D3 75 MG/5600 IU EFERVESAN TABLET, 6 ADET ... Pregvit Folic 5 …
Matched Products: … YUMUŞAK KAPSÜL , 6 KAPSÜL …
Matched Mixtures name: … BONEPLUS D3 75 MG/2800 IU EFERVESAN TABLET, 6 ADET ... RISEPLUS D3 75 MG/5600 IU EFERVESAN TABLET, 6 ADET ... Pregvit Folic 5 …
Matched Products: … YUMUŞAK KAPSÜL , 6 KAPSÜL …
Azithromycin
Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration . It was initially approved by the FDA in 1991 .
It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for...
Approved
Matched Iupac: … -heptamethyl-1-oxa-6-azacyclopentadecan-15-one ... ]oxy}-2-ethyl-3,4,10-trihydroxy-13-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,6,8,10,12,14 ... (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl …
Matched Description: … The results were positive, all patients taking the combination were virologically cured within 6 days …
Matched Products: … TREMAC 250 MG KAPSÜL, 6 KAPSÜL ... ZİTROGEN 250 MG KAPSÜL , 6 ADET ... AZITRO 250 MG FILM KAPLI TABLET, 6 ADET …
Matched Description: … The results were positive, all patients taking the combination were virologically cured within 6 days …
Matched Products: … TREMAC 250 MG KAPSÜL, 6 KAPSÜL ... ZİTROGEN 250 MG KAPSÜL , 6 ADET ... AZITRO 250 MG FILM KAPLI TABLET, 6 ADET …
Pentoxyverine
Pentoxyverine, also referred to as carbetapentane, is a non-opioid central acting antitussive with antimuscarinic, anticonvulsant , and local anesthetic properties. It is an active ingredient in over-the-counter cough suppressants in combination with guaifenesin and H1-receptor antagonists . Pentoxyverine acts on sigma-1 receptors, as well as kappa and mu-opioid receptors.
The...
Approved
Investigational
Withdrawn
Sodium zirconium cyclosilicate
Sodium zirconium cyclosilicate is approved as the trade product Lokelma developed by AstraZeneca - an insoluble, non-absorbed sodium zirconium silicate, formulated as a powder for oral suspension that acts as a highly selective potassium removing agent. It is administered orally and is odorless, tasteless, and stable at room temperature. Approval...
Approved
Investigational
Matched Products: … SIMKELMA 5 G ORAL SÜSPANSİYON HAZIRLAMAK İÇİN TOZ, 28 ADET ... SIMKELMA 5 G ORAL SÜSPANSİYON HAZIRLAMAK İÇİN TOZ, 11 ADET …
Isoprenaline
Isoprenaline is a non-selective beta adrenergic receptor agonist indicated to treat heart block, Adams-Stokes attacks, bronchospasm in anesthesia, cadiac arrest, hypovolemic shocks, septic shock, hypoperfusion, congestive hear failure, and cardiogenic shock.[A15638,L33160]
Isoprenaline research in the 1940s found that this isopropyl analog of epinephrine dilated the bronchi, as well as raising...
Approved
Investigational
Matched Products: … ENAXİL 1 MG/5 ML ENJEKSİYONLUK ÇÖZELTİ, 5 ADET ... ENAXİL 0,2 MG/ML ENJEKSİYONLUK ÇÖZELTİ, 5 ADET ... ENAXİL 1 MG/5 ML ENJEKSİYONLUK ÇÖZELTİ, 1 ADET …
Zidovudine
A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator...
Approved
Matched Iupac: … 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione …
Matched Products: … RETROVİR 50 MG/5 ML ŞURUP ... RETROVİR 200 MG/20 ML IV İNFÜZYONLUK ÇÖZELTİ, 5 ADET …
Matched Products: … RETROVİR 50 MG/5 ML ŞURUP ... RETROVİR 200 MG/20 ML IV İNFÜZYONLUK ÇÖZELTİ, 5 ADET …
Susoctocog alfa
Intravenous susoctocog alfa is a recombinant, B-domain deleted, porcine sequence antihaemophilic factor VIII (FVIII) product that has recently been approved for the treatment of bleeding episodes in adults with acquired haemophilia A (AHA). AHA is a rare bleeding disorder that results in a prolonged clotting time as measured by the...
Approved
Investigational
Ibrutinib
Ibrutinib is a small molecule that acts as an irreversible potent inhibitor of Burton's tyrosine kinase. It is designated as a targeted covalent drug and presented as a promising activity in B-cell malignancies in clinical trials. Ibrutinib was developed by Pharmacyclics Inc and was first approved by the FDA in...
Approved
Chlorquinaldol
Chlorquinaldol was used historically as a topical antiseptic under the trade name Sterosan. It was marketed in the 1950s as an iodine-free alternative which was also unrelated to sulfa drugs or hormones. Chlorquinaldol is currently approved by the European Medicines Agency as a combination tablet with promestriene for the treatment...
Approved
Etelcalcetide
Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. Etelcalcetide was approved (trade name Parsabiv) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis in February, 2017.
Approved
Investigational
Matched Salts cas: … 1334237-71-6 …
Matched Products: … PARSABİV 5 MG/1 ML I.V. ENJEKSİYONLUK ÇÖZELTİ, 6 ADET ... ENJEKSİYONLUK ÇÖZELTİ, 6 ADET ... ENJEKSİYONLUK ÇÖZELTİ, 6 ADET …
Matched Products: … PARSABİV 5 MG/1 ML I.V. ENJEKSİYONLUK ÇÖZELTİ, 6 ADET ... ENJEKSİYONLUK ÇÖZELTİ, 6 ADET ... ENJEKSİYONLUK ÇÖZELTİ, 6 ADET …
Ropivacaine
Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Approved
Matched Synonyms: … (S)-(−)-1-propyl-2',6'-pipecoloxylidide …
Matched Products: … Braun 5 mg/ml Injektionslösung ... Naropin 5 mg/ml - Injektionslösung ... Ropinaest 5 mg/ml - Injektionslösung …
Matched Products: … Braun 5 mg/ml Injektionslösung ... Naropin 5 mg/ml - Injektionslösung ... Ropinaest 5 mg/ml - Injektionslösung …
Displaying drugs 226 - 250 of 7336 in total